RA
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Mercury Systems
MRCY
$4.61B
| $27.2M | 0.08% |
2,396,637
-18,500
| -0.8% | -$231K |
2013 Q2
4 quarters
|
|
|
SYKE
302
DELISTED
SYKES Enterprises Inc
SYKE
| $27.1M | 0.08% |
1,247,927
+80,725
| +7% | +$1.64M |
2013 Q2
4 quarters
|
|
303
Healthcare Services Group
HCSG
$1.44B
| $27M | 0.08% |
918,139
-7,700
| -0.8% | -$227K |
2013 Q2
4 quarters
|
|
304
DELISTED
General Cable Corporation
BGC
| $27M | 0.08% |
1,052,844
+129,300
| +14% | +$3.25M |
2013 Q2
4 quarters
|
|
|
CTG
305
DELISTED
Computer Task Group, Inc.
CTG
| $26.9M | 0.08% |
1,632,047
+831,014
| +104% | +$13.1M |
2013 Q2
4 quarters
|
|
306
Timken Company
TKR
$7.78B
| $26.8M | 0.08% |
551,990
-32,550
| -6% | -$1.48M |
2013 Q2
4 quarters
|
|
307
ICF International
ICFI
$1.55B
| $26.7M | 0.08% |
754,182
+81,732
| +12% | +$3.08M |
2013 Q2
4 quarters
|
|
308
Universal Technical Institute
UTI
$1.12B
| $26.6M | 0.08% |
2,195,183
-50,000
| -2% | -$593K |
2013 Q2
4 quarters
|
|
|
AEGN
309
DELISTED
Aegion Corp
AEGN
| $26.6M | 0.08% |
1,141,453
+51,000
| +5% | +$1.21M |
2013 Q2
4 quarters
|
|
310
NWPX Infrastructure Inc
NWPX
$935M
| $26.5M | 0.08% |
657,583
+33,000
| +5% | +$1.2M |
2013 Q2
4 quarters
|
|
|
AMRI
311
DELISTED
Albany Molecular Research Inc
AMRI
| $26.5M | 0.08% |
1,315,610
-29,000
| -2% | -$491K |
2013 Q2
4 quarters
|
|
312
XPO
XPO
$21.7B
| $26.5M | 0.08% |
2,672,952
+271,649
| +11% | +$2.48M |
2013 Q2
4 quarters
|
|
313
Mettler-Toledo International
MTD
$32.2B
| $26.4M | 0.08% |
104,300
| – | – |
2013 Q2
4 quarters
|
|
314
Ennis
EBF
$566M
| $26.2M | 0.08% |
1,718,206
-72,500
| -4% | -$1.12M |
2013 Q2
4 quarters
|
|
315
ACI Worldwide
ACIW
$5.16B
| $26.1M | 0.08% |
1,401,900
| – | – |
2013 Q2
4 quarters
|
|
316
Upbound Group
UPBD
$900M
| $26M | 0.08% |
908,035
+135,506
| +18% | +$3.83M |
2013 Q2
4 quarters
|
|
317
Curtiss-Wright
CW
$18.5B
| $25.8M | 0.08% |
392,840
-59,000
| -13% | -$3.87M |
2013 Q2
4 quarters
|
|
318
Universal Logistics Holdings
ULH
$444M
| $25.7M | 0.08% |
1,014,900
+100,000
| +11% | +$2.53M |
2013 Q2
4 quarters
|
|
319
ArcBest
ARCB
$2.93B
| $25.7M | 0.08% |
591,520
-75,900
| -11% | -$3.08M |
2013 Q2
4 quarters
|
|
|
ALR
320
DELISTED
Alere Inc
ALR
| $25.7M | 0.08% |
686,700
+71,000
| +12% | +$2.53M |
2013 Q2
4 quarters
|
|
321
Lam Research
LRCX
$359B
| $25.6M | 0.08% |
3,792,740
-335,750
| -8% | -$2.01M |
2013 Q2
4 quarters
|
|
|
ISIL
322
DELISTED
Intersil Corp
ISIL
| $25.6M | 0.08% |
1,709,199
+3,500
| +0.2% | +$47.7K |
2013 Q2
4 quarters
|
|
323
UNIFI
UFI
$106M
| $25.5M | 0.08% |
927,314
-36,120
| -4% | -$850K |
2013 Q2
4 quarters
|
|
|
GBL
324
DELISTED
GAMCO Investors, Inc.
GBL
| $25.5M | 0.08% |
570,470
| – | – |
2013 Q2
4 quarters
|
|
325
Western Digital
WDC
$136B
| $25.5M | 0.08% |
365,393
-30,693
| -8% | -$2.06M |
2013 Q2
4 quarters
|
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.